Huuuge Inc.

Transaction in Own Shares • Apr 22, 2022

Purchase of own shares under the buy-back program

Huuuge, Inc. ("Issuer"), announces that as part of the realization ofthe share buyback program (RB 4/2022 and RB 9/2022) the Issuer haspurchased its own shares (ISIN code: US44853H1086), as follows:

- on April 19th, 2022 - 79,957 shares of the total value of PLN1,376,948.03 , for the average unit price of 17.22 PLN, constituting intotal 0.09% share in the share capital and representing 0.09% in of thetotal number of shares entitled to vote at the stockholder's meeting,

- on April 20th, 2022 - 82,236 shares of the total value of PLN1,487,045.19 for the average unit price of 18.08 PLN, constituting intotal 0.10% share in the share capital and representing 0.10% in thetotal number of shares entitled to vote at the stockholder's meeting,

- on April 21st, 2022 - 84,255 shares of the total value of PLN1,508,721.51, for the average unit price of 17.91 PLN, constituting intotal 0.10% share in the share capital and representing 0.10% in of thetotal number of shares entitled to vote at the stockholder's meeting, and

- on April 22nd, 2022 - 85,627 shares of the total value of PLN1,474,498.50, for the average unit price of PLN 17.22, constituting intotal 0.10% share in the share capital and representing 0.10% in thetotal number of shares entitled to vote at the stockholder's meeting.

The transactions were executed through Ipopema Securities S.A.

Including all transactions above, the Issuer holds 1,717,351 own shares,constituting 2.04% share in the share capital and representing 2.04% inthe total number of shares entitled to vote at the stockholder's meeting(including treasury shares acquired earlier).

Legal basis: Article 2 Section 2 and 3 of Commission DelegatedRegulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU)No 596/2014 of the European Parliament and of the Council with regard toregulatory technical standards for the conditions applicable to buy-backprogrammes and stabilisation measures in accordance with Article 5Section 3 of the MAR.